• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    US Stocks Down; Dow Falls 100 Points

    3/11/24 9:47:56 AM ET
    $CERO
    $DUO
    $ELTK
    $JFBR
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Real Estate
    Finance
    Get the next $CERO alert in real time by email

    U.S. stocks traded lower this morning, with the Dow Jones index dipping around 100 points on Monday.

    Following the market opening Monday, the Dow traded down 0.27% to 38,618.51 while the NASDAQ fell 0.16% to 16,058.93. The S&P 500 also fell, dropping, 0.24% to 5,111.38.

    Check This Out: Cramer Says This Healthcare Stock Can Go Higher, Calls Manhattan Associates 'A Winner'

     

    Leading and Lagging Sectors

     

    Materials shares jumped by 0.6% on Monday.

    In trading on Monday, information technology shares fell by 0.9%.

     

    Top Headline

     

    Eltek Ltd. (NASDAQ:ELTK) posted downbeat earnings for its fourth quarter on Monday.

    Eltek posted quarterly earnings of 22 cents per share, missing market estimates of 31 cents per share.

     

    Equities Trading UP

     

    Kidpik Corp. (NASDAQ:PIK) shares shot up 254% to $9.57. Kidpik recently announced a 1-for 5 reverse stock split.

    Shares of Fangdd Network Group Ltd. (NASDAQ:DUO) got a boost, surging 95% to $1.1780 after the company announced its 2024 strategic layout with plans to enter the real estate stock asset services sector

    TC Biopharm (Holdings) Plc (NASDAQ:TCBP) shares were also up, gaining 69% to $1.79.

     

    Equities Trading DOWN

     

    Eltek Ltd. (NASDAQ:ELTK) shares dropped 22% to $10.90 after the company announced downbeat quarterly earnings.

    Shares of Jeffs' Brands Ltd (NASDAQ:JFBR) were down 24% to $1.20.

    CERo Therapeutics Holdings, Inc. (NASDAQ:CERO) was down, falling 21% to $3.12 after jumping 28% on Friday. CERo Therapeutics recently announced the publication of preclinical research analyzing CER-1236 in targeting Acute Myelogenous Leukemia tumor cells from human patients.

    Also Check This Out: Top 5 Risk Off Stocks That May Plunge This Quarter

     

    Commodities

     

    In commodity news, oil traded down 0.7% to $77.44 while gold traded down 0.1% at $2,184.20.

    Silver traded up 0.3% to $24.615 on Monday while copper rose 0.8% to $3.9220.

     

    Euro zone

     

    European shares were mostly lower today. The eurozone’s STOXX 600 fell 0.4%, London’s FTSE 100 fell 0.3% while Spain’s IBEX 35 Index rose 0.1% The German DAX fell 0.6% French CAC 40 fell 0.2% while Italy’s FTSE MIB Index fell 0.4%.

    Spanish retail trade rose by 0.3% year-over-year in January versus a revised 2.7% gain in the previous month.

     

    Asia Pacific Markets

     

    Asian markets closed mixed on Monday, with Japan’s Nikkei 225 dipping 2.19%, Hong Kong’s Hang Seng Index gaining 1.43%, China’s Shanghai Composite Index gaining 0.74% and India’s S&P BSE Sensex falling 0.81%.

    Chinese vehicle sales dipped by 19.9% year-over-year to 1.58 million units in February versus a 47.9% surge in the prior month. Japanese machine tool orders declined by 8% year-over-year to JPY 114,154 million in February. Japan's GDP expanded by 0.1% quarter-over-quarter in the fourth quarter versus a 0.8% contraction in the third quarter.

     

    Economics

     

    No economic report of significance is due for Monday

    Now Read This: How To Earn $500 A Month From Calavo Growers Ahead Of Q1 Earnings

    Get the next $CERO alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CERO
    $DUO
    $ELTK
    $JFBR

    CompanyDatePrice TargetRatingAnalyst
    CERo Therapeutics Holdings Inc.
    $CERO
    6/23/2025$30.00Hold → Buy
    D. Boral Capital
    Kidpik Corp.
    $PIK
    12/28/2021$10.00Buy
    EF Hutton
    More analyst ratings

    $CERO
    $DUO
    $ELTK
    $JFBR
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Conroy Jeffrey J. sold $1,226,039 worth of Ordinary Shares (3,989,318 units at $0.31) and bought $1,559,675 worth of Ordinary Shares (4,787,320 units at $0.33), increasing direct ownership by 87% to 1,720,002 units (SEC Form 4)

    4 - Jeffs' Brands Ltd (0001885408) (Issuer)

    10/21/24 6:05:27 PM ET
    $JFBR
    Other Specialty Stores
    Consumer Discretionary

    $CERO
    $DUO
    $ELTK
    $JFBR
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    CERo Therapeutics upgraded by D. Boral Capital with a new price target

    D. Boral Capital upgraded CERo Therapeutics from Hold to Buy and set a new price target of $30.00

    6/23/25 8:00:37 AM ET
    $CERO
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    EF Hutton initiated coverage on Kidpik with a new price target

    EF Hutton initiated coverage of Kidpik with a rating of Buy and set a new price target of $10.00

    12/28/21 8:35:50 AM ET
    $PIK
    Catalog/Specialty Distribution
    Consumer Discretionary

    $CERO
    $DUO
    $ELTK
    $JFBR
    SEC Filings

    View All

    SEC Form 6-K filed by Jeffs' Brands Ltd

    6-K - Jeffs' Brands Ltd (0001885408) (Filer)

    2/5/26 5:03:26 PM ET
    $JFBR
    Other Specialty Stores
    Consumer Discretionary

    SEC Form 424B3 filed by CERo Therapeutics Holdings Inc.

    424B3 - CERO THERAPEUTICS HOLDINGS, INC. (0001870404) (Filer)

    2/4/26 9:18:12 AM ET
    $CERO
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    CERo Therapeutics Holdings Inc. filed SEC Form 8-K: Other Events

    8-K - CERO THERAPEUTICS HOLDINGS, INC. (0001870404) (Filer)

    2/4/26 9:12:45 AM ET
    $CERO
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $CERO
    $DUO
    $ELTK
    $JFBR
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Jeffs' Brands: KeepZone AI Announces Exclusive Agreement for the Reselling of Counter Underwater Systems for Drug Smuggling and Protecting Offshore Assets

    Tel Aviv, Israel, Feb. 06, 2026 (GLOBE NEWSWIRE) -- Jeffs' Brands Ltd ("Jeffs' Brands" or the "Company") (NASDAQ:JFBR, JFBRW)), a data-driven e-commerce company operating on the Amazon Marketplace expanding into the global homeland security sector through advanced artificial intelligence ("AI") -driven solutions, today announced that its wholly-owned subsidiary, KeepZone AI Inc. ("KeepZone"), has entered into an exclusive reseller agreement (the "Agreement") with DSIT Solutions Ltd. ("DSIT"), a global leader in underwater domain awareness and acoustic intelligence solutions. KeepZone will help lead DSIT's entry into the Mexican market to counter underwater drug smuggling and protect offsh

    2/6/26 7:47:00 AM ET
    $JFBR
    Other Specialty Stores
    Consumer Discretionary

    CERo Therapeutics to Present Late-Breaking Oral Poster Session Highlighting Interim Phase 1 Data from CERTAIN-T Trial Highlighting Platelet Transfusion Independence in a High-Risk MDS/AML Patient

    Poster to be presented at Tandem Meeting of the American Society of Transplantation and Cellular Therapy (ASTCT) and the Center for International Blood and Marrow Transplant Research (CIBMTR) on February 5, 2026 SOUTH SAN FRANCISCO, Calif., Feb. 04, 2026 (GLOBE NEWSWIRE) -- CERo Therapeutics Holdings, Inc., (OTCQB:CERO) ("CERo" or the "Company"), an innovative cellular immunotherapy company pursuing new targets and novel phagocytic mechanisms, announces a presentation highlighting data to date from the Company's Phase 1 clinical trial, called CERTAIN-T, of its lead compound, CER-1236.  Reflective of the Company's recent clinical update,  the data highlight results from the first cohort

    2/4/26 9:05:00 AM ET
    $CERO
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Jeffs' Brands' KeepZone AI Will Serve as Hydrogen-Powered Drone Systems' Prime Contractor to Support Government and Defense Clients

    Tel Aviv, Israel, Feb. 02, 2026 (GLOBE NEWSWIRE) -- Jeffs' Brands Ltd ("Jeffs' Brands" or the "Company") (NASDAQ:JFBR, JFBRW)), a data-driven e-commerce company operating on the Amazon Marketplace expanding into the global homeland security sector through advanced artificial intelligence ("AI")-driven solutions, today announced that its wholly-owned subsidiary, KeepZone AI Inc. ("KeepZone"), has secured exclusive rights in Mexico under a commercial agreement (the "Agreement") with an advanced drone manufacturer(the "Advanced Drone Manufacturer ") specializing in hydrogen-powered drones. Pursuant to the Agreement KeepZone has been granted exclusive rights in Mexico to market, sell and sup

    2/2/26 8:12:00 AM ET
    $JFBR
    Other Specialty Stores
    Consumer Discretionary

    $CERO
    $DUO
    $ELTK
    $JFBR
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Director Laporte Kathleen

    4 - CERO THERAPEUTICS HOLDINGS, INC. (0001870404) (Issuer)

    1/9/26 4:30:22 PM ET
    $CERO
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    SEC Form 4 filed by Chief Development Officer Pierce Kristen

    4 - CERO THERAPEUTICS HOLDINGS, INC. (0001870404) (Issuer)

    1/9/26 4:30:21 PM ET
    $CERO
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    SEC Form 4 filed by Director Patel Shami

    4 - CERO THERAPEUTICS HOLDINGS, INC. (0001870404) (Issuer)

    1/9/26 4:30:19 PM ET
    $CERO
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $CERO
    $DUO
    $ELTK
    $JFBR
    Financials

    Live finance-specific insights

    View All

    CERo Therapeutics Provides Clinical Update on Phase 1 Trial of CER-1236 in AML (CertainT-1) Highlighting Key Safety Data and Platelet Transfusion–Free Interval Observed in a Patient with Myelodysplastic Syndrome/AML

    Company to host analyst call at 5:00pm ET today to discuss progress to date and expansion of clinical trial SOUTH SAN FRANCISCO, Calif, Jan. 07, 2026 (GLOBE NEWSWIRE) -- CERo Therapeutics Holdings, Inc., (OTCQB:CERO) ("CERo" or the "Company"), an innovative cellular immunotherapy company pursuing new targets and novel phagocytic mechanisms, announces a key clinical update from the Company's ongoing CertainT-1 trial focused on patients with acute myeloid leukemia (AML). Following completion of the dose-limiting toxicity (DLT) observation period for the first cohort, investigators observed cell expansion with no CRS, ICANS, or treatment-related adverse events reported to date. Expansion w

    1/7/26 9:09:00 AM ET
    $CERO
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Eltek Ltd. Reports 2025 Third Quarter Financial Results

    PETACH TIKVA, Israel, Nov. 18, 2025 /PRNewswire/ -- Eltek Ltd. (NASDAQ:ELTK), a global manufacturer and supplier of technologically advanced solutions in the field of printed circuit boards (PCBs), today announced its financial results for the quarter ended September 30, 2025. Third Quarter 2025 Highlights Revenues were $13.3 million compared to $13.5 million in Q3 2024Operating income was $0.05 million compared to $1.9 million in Q3 2024Net loss was $0.2 million, or $0.03 per fully diluted shareAs of September 30, 2025, cash, cash equivalents and short-term deposits amounted $11.6 million"The Company reported third-quarter sales of $13.3 million and nine-month sales of $38.6 million for th

    11/18/25 7:30:00 AM ET
    $ELTK
    Electrical Products
    Technology

    Eltek Sets Earnings Release Date and Conference Call to Report Third Quarter 2025 Results on November 18, 2025

    PETACH-TIKVA, Israel, Nov. 10, 2025 /PRNewswire/ -- Eltek Ltd. (NASDAQ:ELTK), a global manufacturer and supplier of technologically advanced solutions in the field of printed circuit boards, announced today that it will release its financial results for the third quarter of 2025 before the market opens on Tuesday, November 18, 2025. Eltek's financial results will be released over the news wires and will be posted on its corporate website at: http://www.nisteceltek.com.  On Tuesday, November 18, 2025, at 9:00 a.m. Eastern Time, Eltek will conduct a conference call to discuss the results. The call will feature remarks by Eli Yaffe, Chief Executive Officer and Ron Freund, Chief Financial Offic

    11/10/25 7:30:00 AM ET
    $ELTK
    Electrical Products
    Technology

    $CERO
    $DUO
    $ELTK
    $JFBR
    Leadership Updates

    Live Leadership Updates

    View All

    Jeffs' Brands Appoints Security Executive Alon Dayan as CEO of KeepZone AI Inc., Strengthening Leadership in Global Homeland Security Expansion

    Tel Aviv, Israel, Dec. 08, 2025 (GLOBE NEWSWIRE) -- Jeffs' Brands Ltd ("Jeffs' Brands" or the "Company") (NASDAQ:JFBR, JFBRW)), a data-driven e-commerce company operating on the Amazon Marketplace, today announced the appointment of Alon Dayan as Chief Executive Officer ("CEO") of its wholly-owned subsidiary, KeepZone AI Inc., formerly known as Jeffs' Brands Holdings Inc. ("KeepZone"). This strategic appointment comes on the heels of KeepZone's recent entry into the global homeland security market through a definitive distribution agreement with Scanary Ltd. ("Scanary"), positioning the Company to capitalize on the surging demand for advanced AI-driven threat detection technologies. Alon

    12/8/25 9:10:00 AM ET
    $JFBR
    Other Specialty Stores
    Consumer Discretionary

    Jeffs' Brands Announces Record First Half Results- Revenues amounted to approximately $6.9 million in H1 2025

    Company presented operation profit for its logistics operations operated by Pure Logistics in Q2 2025 financial results Tel Aviv, Israel, Sept. 22, 2025 (GLOBE NEWSWIRE) -- Jeffs' Brands Ltd ("Jeffs' Brands" or the "Company") (NASDAQ:JFBR, JFBRW)), a data-driven e-commerce company operating on the Amazon Marketplace, today announced operational highlights for the six month period ended June 30, 2025. First half and recent highlights: Revenues for the first six months of 2025 increased to approximately $6.9 million, representing record revenues for the first six months as compared to previous periods and an approximately 13% growth, compared to approximately $6.1 million in the same per

    9/22/25 7:25:00 AM ET
    $JFBR
    Other Specialty Stores
    Consumer Discretionary

    Jeffs' Brands Appoints Accomplished Capital Markets and Experience M&A Professional as Chief Executive Officer

    Tel Aviv, Israel, July 21, 2025 (GLOBE NEWSWIRE) -- Jeffs' Brands Ltd ("Jeffs' Brands" or the "Company") (NASDAQ:JFBR, JFBRW)), a data-driven e-commerce company operating on the Amazon Marketplace, today announced the appointment of Mr. Eliyahu Zamir as the Company's new Chief Executive Officer, effective as of August 1, 2025. Mr. Eliyahu Zamir will replace Mr. Viki Hakmon, who will step down from his position as the Company's Chief Executive Officer, effective as of July 31, 2025. On July 21, 2025, Mr. Hakmon also resigned from the Board of Directors, effective immediately. Mr. Hakmon's resignation did not result from any disagreements with the Company or the Board of Directors and he wi

    7/21/25 7:32:00 AM ET
    $FORTY
    $JFBR
    EDP Services
    Technology
    Other Specialty Stores
    Consumer Discretionary

    $CERO
    $DUO
    $ELTK
    $JFBR
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Fangdd Network Group Ltd.

    SC 13G - Fangdd Network Group Ltd. (0001750593) (Subject)

    12/16/24 4:26:40 PM ET
    $DUO
    Real Estate
    Finance

    Amendment: SEC Form SC 13G/A filed by Fangdd Network Group Ltd.

    SC 13G/A - Fangdd Network Group Ltd. (0001750593) (Subject)

    12/16/24 4:24:27 PM ET
    $DUO
    Real Estate
    Finance

    SEC Form SC 13G filed by CERo Therapeutics Holdings Inc.

    SC 13G - CERO THERAPEUTICS HOLDINGS, INC. (0001870404) (Subject)

    12/13/24 7:18:17 PM ET
    $CERO
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care